Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
TuHURA Biosciences (HURA US)
Watchlist
5
Analysis
Health Care
•
United States
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company. The Company focuses on developing technologies to overcome resistance to cancer immunotherapy. TuHURA Biosciences operates in the United States.
more
Watchlist
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
06 Dec 2025 06:00
Current Report (Form 8-K | Period ending 2025-12-02)
Attachment
Exchange Announcement •
25 Nov 2025 21:01
Current Report (Form 8-K | Period ending 2025-11-25)
Attachment
Exchange Announcement •
25 Nov 2025 21:00
424B3 | Prospectus
Attachment
Exchange Announcement •
19 Nov 2025 06:03
Current Report (Form 8-K | Period ending 2025-11-18)
Attachment
Exchange Announcement •
14 Nov 2025 20:20
Quarterly Report (Form 10-Q | Period ending 2025-09-30)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x